Oral administration of polymyxin b modulates the activity of lipooligosaccharide e. coli b against lung metastases in murine tumor models

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Kicielińska, Jagoda ^a   Szczygiel, Agnieszka ^a   Rossowska, Joanna ^a   Anger, Natalia ^a   Kempińska, Katarzyna ^a   Switalska, Marta ^a   Kaszowska, Marta ^a   Wietrzyk, Joanna ^a   Boratyński, Janusz ^a   Pajtasz Piasecka, Elzbieta ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LIPOOLIGOSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA; CONCANAVALIN A; CYTOKINE; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EX VIVO STUDY; FEMALE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEWIS LUNG CARCINOMA CELL; LUNG METASTASIS; MACROPHAGE CULTURE; MELANOMA B16; METASTASIS INHIBITION; MOUSE; NONHUMAN; PERITONEUM CELL; TREATMENT DURATION; TUMOR IMMUNITY; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CHEMISTRY; DENDRITIC CELL; DISEASE MODEL; DRUG EFFECTS; ESCHERICHIA COLI; EXPERIMENTAL MELANOMA; INTRAVENOUS DRUG ADMINISTRATION; LEWIS CARCINOMA; LUNG; LUNG TUMOR; LYMPHOCYTE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PERITONEUM MACROPHAGE; PHENOTYPE; SECONDARY; SPLEEN;

ADMINISTRATION, ORAL; ANIMALS; CARCINOMA, LEWIS LUNG; CONCANAVALIN A; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LUNG; LUNG NEOPLASMS; LYMPHOCYTES; MACROPHAGES, PERITONEAL; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; PHENOTYPE; POLYMYXIN B; SPLEEN;

EID: 84958780959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148156     Document Type: Article

References (28)

1. McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J. 2006; 26:154-8. PMID: 16789469
2. Tzeng Y-L, Datta A, Kolli VK, Carlson RW, Stephens DS. Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase. J Bacteriol. 2002; 184(9):2379-88. PMID: 11948150
3. Hershberger C, Davis M, Binkley SB. Chemistry and Metabolism of 3-Deoxy-d-mannooctulosonic Acid II. PRACTICAL SYNTHESIS AND STABILITY. J Biol Chem. 1968; 243(7):1585-8. PMID: 5647273
4. Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, i in. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leukoc Biol. 2003; 74(6):1045-55. PMID: 12960272
5. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, i in. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998; 282(5396):2085-8. PMID: 9851930
6. Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002; 71:635-700. PMID: 12045108
7. Kaszowska M, Niedziela T, Maciejewska A, Lukasiewicz J, Jachymek W, Lugowski C. Core oligosaccharide of Escherichia coli B-the structure required for bacteriophage T4 recognition. Carbohydr Res. 2015; 413:51-4. doi: 10.1016/j.carres.2015.04.023 PMID: 26091777
8. Mares J, Kumaran S, Gobbo M, Zerbe O. Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy. J Biol Chem. 2009; 284(17):11498-506. doi: 10.1074/jbc.M806587200 PMID: 19244241
9. Valentinis B, Bianchi A, Zhou D, Cipponi A, Catalanotti F, Russo V, i in. Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-Alpha/NF-kappaB and ERK1/2 pathways and adhesion. J Biol Chem. 2005; 280(14):14264-71. PMID: 15671028
10. Wolfert MA, Roychowdhury A, Boons G-J. Modification of the Structure of Peptidoglycan Is a Strategy To Avoid Detection by Nucleotide-Binding Oligomerization Domain Protein 1. Infect Immun. 2007; 75 (2):706-13. PMID: 17145940
11. Malleshappa P, Ranganath R, Chaudhari AP, Singhai P, Aghariya M, Shah AB. Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis. Indian J Nephrol. 2011; 21(1):41-3. doi: 10.4103/0971-4065.78077 PMID: 21655169
12. Galanos C, Lüderitz O, Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem FEBS. 1969; 9(2):245-9.
13. Rossowska J, Pajtasz-Piasecka E, Szyda A, Zietara N, Du D. Tissue localization of tumor antigenloaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response. Folia Histochem Cytobiol Pol Acad Sci Pol Histochem Cytochem Soc. 2007; 45(4):349-55.
14. Rossowska J, Pajtasz-Piasecka E, Szyda A, Krawczenko A, Zietara N, Dus D. Tumour antigen-loaded mouse dendritic cells maturing in the presence of inflammatory cytokines are potent activators of immune response in vitro but not in vivo. Oncol Rep. 2009; 21(6):1539-49. PMID: 19424635
15. Miernikiewicz P, Dbrowska K, Piotrowicz A, Owczarek B, Wojas-Turek J, Kicieliska J, i in. T4 phage and its head surface proteins do not stimulate inflammatory mediator production. PloS One. 2013; 8(8): e71036. doi: 10.1371/journal.pone.0071036 PMID: 23976975
16. Rossowska J, Anger N, Kicieliska J, Pajtasz-Piasecka E, Bielawska-Pohl A, Wojas-Turek J, i in. Temporary elimination of IL-10 enhanced the effectiveness of cyclophosphamide and BMDC-based therapy by decrease of the suppressor activity of MDSCs and activation of antitumour immune response. Immunobiology. 2015; 220(3):389-98. doi: 10.1016/j.imbio.2014.10.009 PMID: 25454807
17. Chamberlain LM, Godek ML, Gonzalez-Juarrero M, Grainger DW. Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models. J Biomed Mater Res A. 2009; 88(4):858-71. doi: 10.1002/jbm.a.31930 PMID: 18357567
18. Preston A, Mandrell RE, Gibson BW, Apicella MA. The Lipooligosaccharides of Pathogenic Gram-Negative Bacteria. Crit Rev Microbiol. 1996; 22(3):139-80. PMID: 8894399
19. Ferrari D, Pizzirani C, Adinolfi E, Forchap S, Sitta B, Turchet L, i in. The antibiotic polymyxin B modulates P2X7 receptor function. J Immunol Baltim Md 1950. 2004; 173(7):4652-60.
20. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006; 10(1):R27. PMID: 16507149
21. Yoshino N, Endo M, Kanno H, Matsukawa N, Tsutsumi R, Takeshita R, i in. Polymyxins as novel and safe mucosal adjuvants to induce humoral immune responses in mice. PloS One. 2013; 8(4):e61643. doi: 10.1371/journal.pone.0061643 PMID: 23593492
22. Gaston JSH. Heat shock proteins and innate immunity. Clin Exp Immunol. 2002; 127(1):1-3. PMID: 11882025
23. Ghosn EEB, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, i in. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A. 9 2010; 107(6):2568-73. doi: 10.1073/pnas.0915000107 PMID: 20133793
24. Ruggiero V, D'Urso CM, Albertoni C, Campo S, Foresta P, Martelli EA. LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives. Mediators Inflamm. 1993; 2(7):S43-50. PMID: 18475570
25. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998; 393(6684):474-8. PMID: 9624003
26. Abdi K, Singh NJ, Matzinger P. Lipopolysaccharide-Activated dendritic cells: "exhausted" or alert and waiting? J Immunol Baltim Md 1950. 2012; 188(12):5981-9.
27. Kamath AT, Sheasby CE, Tough DF. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-Alpha beta and IFN-gamma. J Immunol Baltim Md 1950. 2005; 174(2):767-76.
28. Bao Y, Liu X, Han C, Xu S, Xie B, Zhang Q, i in. Identification of IFN-?-producing innate B cells. Cell Res. luty 2014; 24(2):161-76.